LAL-D Features

Gamida Cell warehouse team

Omidubicel Shows Promise as Replacement for Umbilical Cord Blood in Stem Cell Transplants

Gamida Cell is gearing up to begin sales of omidubicel from Israel to US hospitals for use in stem cell transplants, pending FDA approval of the therapy.

At 40, Orphan Drug Act Enjoys Rare Bipartisan Support

Rare disease advocates are marking the 40th anniversary of the landmark Orphan Drug Act, which has led to over 1100 approvals for new therapies.

Next post in Features